drugset / Trial / NCT02084771
Oral Salt and Water to Prevent Contrast Nephropathy
RandomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this pilot trial is to determine the safety and feasibility of using oral salt and water loading compared to intravenous saline for the prevention of contrast-induced acute kidney injury in patients with chronic kidney disease receiving a contrast-enhanced CT scan.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-12
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salt and Water | Unknown | 0.1 g/kg | Oral |
| Comparator | sodium chloride | Unknown | — | Intravenous |